跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32 条关于
“CADENZA”
全部
32
临床试验
21
药物
1
机构
3
资讯
7
去年
Novel Antibody-Drug Conjugate Achieves 85% Response Rate in Rare Blood Cancer Trial
去年
FDA Approves Sanofi's Enjaymo: First Targeted Therapy for Rare Blood Disorder CAD
11个月前
AbbVie Submits FDA Application for Pivekimab Sunirine to Treat Rare Blood Cancer BPDCN
3个月前
FDA Approves Pivekimab Sunirine as First ADC for Ultra-Rare Blood Cancer BPDCN
4个月前
AbbVie Launches Pivotal Phase 2/3 Revival Trial of Pivekimab Sunirine in First-Line AML, Expands into Pediatric Setting
11个月前
Cadence Launches ROCS X AI Platform for Drug Discovery, Enabling Trillion-Molecule Virtual Screening
去年
CADENCE and Medera Launch Asia's First Multi-Centre Gene Therapy Trial for Heart Failure in Singapore